Attached files

file filename
8-K/A - 8-K/A - RiceBran Technologiesform8ka.htm

Exhibit 99.2

Unaudited Pro Forma Financial Statements

On July 14, 2017, Rice Bran Technologies (the Company) completed the sale of Healthy Natural, Inc., (HN) its wholly-owned subsidiary, pursuant to an asset purchase agreement (Purchase Agreement) previously reported in the Company’s current report on Form 8-K filed with the SEC on July 17, 2017.

The unaudited pro forma financial statements have been developed by applying pro forma adjustments to The Company’s historical consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America and give effect to the divestiture of Healthy Natural, Inc.  The unaudited pro forma condensed statements of operations for the three months ended March 31, 2017 and 2016, and for the years ended December 31, 2016 and 2015, assume that the divestiture of Healthy Natural, Inc. occurred January 1, 2015. The unaudited pro forma balance sheet as of March 31, 2017, assumes that the divestiture occurred on that date.  The unaudited pro forma condensed consolidated financial statements are presented based on currently available information and are intended for informational purposes only.

These unaudited pro forma condensed consolidated financial statements are not necessarily indicative of what the Company’s results of operations or financial condition would have been had the divestiture been completed on the dates assumed.  In addition, they are not necessarily indicative of the Company’s future results of operations or financial condition.  Beginning in the second quarter of 2017, the historical financial results of Healthy Natural, Inc., for periods prior to the divestiture will be reflected in the Company’s consolidated financial statements as discontinued operations.

The unaudited pro forma financial statements should be read in conjunction with (i) the accompanying notes to the unaudited pro forma condensed consolidated financial statements, (ii) the audited consolidated financial statements and accompanying notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Company’s Form 10-K for the year ended December 31, 2016, filed with the SEC on March 23, 2017, and (iii) the unaudited condensed consolidated financial statements and accompanying notes and “Management’s Discussion and Analysis of Financial Conditions and Results of Operations” included in the Company’s Form 10-Q for the three months ended March 31, 2017, filed with the SEC on May 12, 2017.


RiceBran Technologies
Pro Forma Condensed Consolidated Statements of Operations
Unaudited Three Months Ended March 31, 2017
 (in thousands, except share and per share amounts)

   
Historical
   
HN Divestiture
Pro Forma
Adjustments
   
Notes
   
Pro Forma
 
                         
Revenues
 
$
11,435
   
$
(4,418
)
 
(a)
   
$
7,017
 
Cost of goods sold
   
8,924
     
(3,022
)
 
(a)
     
5,902
 
Operating expenses
   
3,027
     
(227
)
 
(b)
     
2,800
 
Other expense
   
2,085
     
(1
)
 
(c)
         
             
(362
)
 
(g)
     
1,722
 
Loss before income taxes
   
(2,601
)
                 
(3,407
)
Income taxes
   
-
     
409
   
(i)
     
409
 
Net loss
   
(2,601
)
                 
(2,998
)
Net loss attributable to noncontrolling interest
   
319
                   
319
 
Net loss attributable to shareholders
   
(2,282
)
                 
(2,679
)
Dividends on preferred stock--beneficial conversion feature
   
(778
)
                 
(778
)
Net loss attributable to common shareholders
 
$
(3,060
)
                
$
(3,457
)
                               
Loss per share attributable to common shareholders
                             
Basic
 
$
(0.32
)
                
$
(0.36
)
Diluted
 
$
(0.32
)
                
$
(0.36
)
                               
Weighted average number of shares outstanding
                             
Basic
   
9,657,543
                   
9,657,543
 
Diluted
   
9,657,543
                   
9,657,543
 

See Notes to Pro Forma Unaudited Condensed Consolidated Financial Statements


RiceBran Technologies
Pro Forma Condensed Consolidated Statements of Operations
Unaudited Three Months Ended March 31, 2016
(in thousands, except share and per share amounts)

   
Historical
   
HN Divestiture
Pro Forma
Adjustments
   
Notes
   
Pro Forma
 
                         
Revenues
 
$
10,051
   
$
(4,488
)
 
(a)
   
$
5,563
 
Cost of goods sold
   
7,814
     
(2,959
)
 
(a)
     
4,855
 
Operating expenses
   
3,727
     
(374
)
 
(b)
     
3,353
 
Other income
   
(1,352
)
                 
(1,352
)
Loss before income taxes
   
(138
)
                 
(1,293
)
Income taxes
   
-
     
404
   
(i)
     
404
 
Net loss
   
(138
)
                 
(889
)
Net loss attributable to noncontrolling interest
   
438
                   
438
 
Net loss attributable to shareholders
   
300
                   
(451
)
Dividends on preferred stock--beneficial conversion feature
   
(551
)
                 
(778
)
Net loss attributable to common shareholders
 
$
(251
)
                
$
(1,229
)
                               
Loss per share attributable to common shareholders
                             
Basic
 
$
(0.03
)
                
$
(0.13
)
Diluted
 
$
(0.03
)
                
$
(0.13
)
                               
Weighted average number of shares outstanding
                             
Basic
   
9,215,684
                   
9,215,684
 
Diluted
   
9,215,684
                   
9,215,684
 

See Notes to Pro Forma Unaudited Condensed Consolidated Financial Statements


RiceBran Technologies
Pro Forma Condensed Consolidated Statements of Operations
Unaudited Year Ended December 31, 2016
(in thousands, except share and per share amounts)

   
Historical
   
HN Divestiture
Pro Forma
Adjustments
   
Notes
   
Pro Forma
 
                         
Revenues
 
$
39,405
   
$
(19,677
)
 
(a)
   
$
19,728
 
Cost of goods sold
   
31,436
     
(13,158
)
 
(a)
     
18,278
 
Operating expenses
   
19,100
     
(1,438
)
 
(b)
     
17,662
 
Other (income) expense, net
   
78
     
(2
)
 
(c)
         
             
(1,098
)
 
(g)
     
(1,022
)
Loss before income taxes
   
(11,209
)
                 
(15,190
)
Income taxes
   
(41
)
   
1,778
   
(i)
     
1,737
 
Net loss
   
(11,250
)
                 
(13,453
)
Net loss attributable to noncontrolling interest
   
2,720
                   
2,720
 
Net loss attributable to shareholders
   
(8,530
)
                 
(10,733
)
Dividends on preferred stock--beneficial conversion feature
   
(551
)
                 
(778
)
Net loss attributable to common shareholders
 
$
(9,081
)
                
$
(11,511
)
                               
Loss per share attributable to common shareholders
                             
Basic
 
$
(0.97
)
                
$
(1.23
)
Diluted
 
$
(0.97
)
                
$
(1.23
)
                               
Weighted average number of shares outstanding
                             
Basic
   
9,338,370
                   
9,338,370
 
Diluted
   
9,338,370
                   
9,338,370
 

See Notes to Pro Forma Unaudited Condensed Consolidated Financial Statements


RiceBran Technologies
Pro Forma Condensed Consolidated Statements of Operations
Unaudited Year Ended December 31, 2015
(in thousands, except share and per share amounts)

   
Historical
   
HN Divestiture
Pro Forma
Adjustments
   
Notes
   
Pro Forma
 
                         
Revenues
 
$
39,896
   
$
(12,845
)
 
(a)
   
$
27,051
 
Cost of goods sold
   
31,826
     
(8,716
)
 
(a)
     
23,110
 
Operating expenses
   
14,346
     
(1,738
)
 
(b)
     
12,608
 
Other expense, net
   
4,476
                   
4,476
 
Loss before income taxes
   
(10,752
)
                 
(13,143
)
Income taxes
   
176
     
837
   
(i)
     
1,013
 
Net loss
   
(10,576
)
                 
(12,130
)
Net loss attributable to noncontrolling interest
   
2,308
                   
2,308
 
Net loss attributable to shareholders
   
(8,268
)
                 
(9,822
)
Dividends on preferred stock--beneficial conversion feature
   
-
                   
(778
)
Net loss attributable to common shareholders
 
$
(8,268
)
                
$
(10,600
)
                               
Loss per share attributable to common shareholders
                             
Basic
 
$
(0.90
)
                
$
(1.15
)
Diluted
 
$
(0.90
)
                
$
(1.15
)
                               
Weighted average number of shares outstanding
                             
Basic
   
9,187,983
                   
9,187,983
 
Diluted
   
9,187,983
                   
9,187,983
 

See Notes to Pro Forma Unaudited Condensed Consolidated Financial Statements


RiceBran Technologies
Pro Forma Condensed Consolidated Balance Sheets
Unaudited March 31, 2017
(in thousands, except share amounts)

   
Historical
   
HN Divestiture
Pro Forma
Adjustments
   
Notes
   
Pro Forma
 
ASSETS
                       
Cash and cash equivalents
 
$
3,366
   
$
17,349
   
(e)
       
             
(12,563
)
 
(f)
   
$
8,152
 
Accounts receivable, net
   
2,944
     
(592
)
 
(d)
     
2,352
 
Inventories
   
4,028
     
(1,915
)
 
(d)
     
2,113
 
Deposits and other current assets
   
904
     
(23
)
 
(d)
     
881
 
Property and equipment, net
   
18,881
     
(1,019
)
 
(d)
     
17,862
 
Goodwill
   
790
     
(790
)
 
(d)
     
-
 
Intangible assets, net
   
206
                   
206
 
Operating taxes recoverable
   
1,203
                   
1,203
 
Other long-term assets
   
141
     
(25
)
 
(d)
     
116
 
Total assets
 
$
32,463
                  
$
32,885
 
                               
LIABILITIES
                             
Accounts payable and accruals
 
$
11,086
     
(825
)
 
(d)
         
             
4,594
   
(h)
   
$
14,855
 
Long-term debt
   
13,003
     
(45
)
 
(d)
         
             
(5,509
)
 
(f)
     
7,449
 
Derivative warrant liabilities
   
494
                   
494
 
Deferred tax liability
   
29
                   
29
 
Total liabilities
   
24,612
                   
22,827
 
                               
EQUITY
                             
Preferred stock
   
1,545
                   
1,545
 
Common stock
   
273,853
                   
273,853
 
Accumulated deficit
   
(262,879
)
   
9,261
   
(h)
         
             
(7,054
)
 
(f)
     
(260,672
)
Accumulated deficit attributable to noncontrolling interest
   
(416
)
                 
(416
)
Accumulated other comprehensive loss
   
(4,252
)
                 
(4,252
)
Total equity
   
7,851
                   
10,058
 
Total liabilities and equity
 
$
32,463
                  
$
32,885
 

See Notes to Pro Forma Unaudited Condensed Consolidated Financial Statements


RiceBran Technologies
Notes to Pro Forma Unaudited Condensed Consolidated Financial Statements

The unaudited pro forma financial statements give effect to the sale of Healthy Natural, Inc. (the Asset Sale) to be accounted for as a discontinued operation. The unaudited pro forma statements of operations for the three months ended March 31, 2017 and 2016, and for the years ended December 31, 2016 and 2015, are presented as if the sale occurred as of the beginning of those periods.  The unaudited pro forma balance sheet as of March 31, 2017, is presented as if the sale occurred on that date.

(a)
This adjustment reflects the elimination of revenues and cost of goods sold of Healthy Natural, Inc.
(b)
This adjustment reflects the elimination of operating expenses of Healthy Natural, Inc., excluding the anticipated effects of other costs that may be reduced or eliminated as a result of having completed the sale.
(c)
This adjustment reflects the elimination of interest expense related to of Healthy Natural, Inc. debt.
(d)
This adjustment reflects the elimination of the historical assets and liabilities of Healthy Natural, Inc.
(e)
This adjustment reflects the cash consideration received at closing of the Asset Sale net of $219 thousand of assumed liabilities, $519 thousand of advisory fees and $365 thousand of other costs of the Asset Sale.
(f)
This adjustment reflects the repayment of certain non-Healthy Natural, Inc. debt from proceeds of the Asset Sale and the estimated expense arising from the extinguishment of that debt.  This estimated expense arising from the extinguishment has not been reflected in the pro forma statements of operations as it is considered to be nonrecurring in nature.
(g)
This adjustment reflects the elimination of interest expense on the registrant debt referred to in footnote (f).
(h)
This adjustment reflects the estimated gain arising from the transaction. The estimated gain has not been reflected in the accompanying statements of operations as it is considered to be nonrecurring in nature.  No adjustment has been made to the sales proceeds to give effect to any potential post-closing adjustments under the terms of the Purchase Agreement.  The estimated gain includes a provision for income taxes of $4.6 million. which may be due on the Asset Sale.  The Internal Revenue Service rules in this area are complex and the registrant has not yet completed an analysis of what net operating losses, if any, will be available to reduce the taxes owed on the gain.
(i)
This adjustment reflects income tax expense of 35% on adjustments (a), (b) and (c).